"Als größtes Universitätsklinikum im Norden deckt das UKSH mit 92 Kliniken und Instituten in Kiel und Lübeck das gesamte Spektrum der modernen Medizin ab. 500.000 Patientinnen und Patienten profitieren jedes Jahr von der engen Verknüpfung der Spitzenmedizin des UKSH mit der innovativen Forschung der Universitäten in Kiel und Lübeck. Forschungsergebnisse gelangen hier direkt in die medizinische Praxis. Das Ergebnis ist ein exzellentes klinisches Niveau: Das UKSH ist Garant für höchst individualisierte sowie interdisziplinäre Diagnostik und Therapie. Dazu zählen medizinische Innovationen wie die Präzisionsmedizin für chronische Entzündungserkrankungen und Krebserkrankungen ebenso wie die digitalen Medien."

During the past decade, Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored, "CENTOGENE GmbH Rostock" with 1 trials sponsored, "German Parkinson Study Group (GPS)" with 1 trials sponsored and "Jena University Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie" #1 collaborator was "Competence Network on Parkinson's Disease" with 1 trials as a collaborator, "European MSA-Study Group" with 1 trials as a collaborator and "Federal Institute of Education and Sience" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie" are "Multiple Sclerosis" (2 trials), "Autoimmune Encephalitis" (1 trials), "Epilepsy With Partial Onset Seizures With or Without Secondary Generalization" (1 trials), "Minocycline" (1 trials) and "Multi-System-Atrophy" (1 trials). Many other conditions were trialed in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Antihistamine" (2 trials), "Methylprednisolone" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (2 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Schleswig-Holstein; Klinik für Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".